McPherson's (ASX:MCP) - 주가, 뉴스 및 분석

MCP 주식 개요

맥퍼슨은 호주, 뉴질랜드, 아시아 및 전 세계에 건강, 웰빙, 미용 제품을 공급하는 회사입니다. 자세한 내용

MCP 기본 분석
눈송이 점수
가치 평가	4/6
미래 성장	0/6
과거 실적	0/6
재무 상태	6/6
배당금	0/6

보상

공정 가치 추정치보다 낮은 53.9% 에서 거래

위험 분석

지난 5년간 매년 수익이 65.3% 씩 감소했습니다.

의미 있는 시가총액이 없습니다. ( A$56M )

McPherson's Limited 경쟁사

BWX

ASX:BWX

AU$40.0m

Star Combo Pharma

ASX:S66

AU$15.5m

Elixinol Wellness

ASX:EXL

AU$8.8m

Calmer Co International

ASX:CCO

AU$16.5m

가격 내역 및 성능

다음에 대한 모든 사상 최고가, 변동 및 가격 하락 요약 McPherson's
과거 주가
현재 주가	AU$0.39
52주 최고치	AU$0.67
52주 최저치	AU$0.37
베타	0.75
11개월 변경	-2.50%
3개월 변경 사항	-14.75%
1년 변경 사항	-22.00%
33년 변화	-56.18%
5년 변화	-83.75%
IPO 이후 변화	-72.92%

최근 뉴스 및 업데이트

McPherson's Limited's (ASX:MCP) Share Price Not Quite Adding Up

Aug 01

Recent updates

McPherson's Limited's (ASX:MCP) Share Price Not Quite Adding Up

Aug 01

McPherson's Limited's (ASX:MCP) Shares Climb 35% But Its Business Is Yet to Catch Up

Dec 18

These 4 Measures Indicate That McPherson's (ASX:MCP) Is Using Debt Reasonably Well

May 17

Did You Participate In Any Of McPherson's' (ASX:MCP) Fantastic 149% Return ?

Feb 12

Are McPherson's's (ASX:MCP) Statutory Earnings A Good Guide To Its Underlying Profitability?

Jan 25

Declining Stock and Decent Financials: Is The Market Wrong About McPherson's Limited (ASX:MCP)?

Jan 07

A Look At The Intrinsic Value Of McPherson's Limited (ASX:MCP)

Dec 20

Analysts Just Shaved Their McPherson's Limited (ASX:MCP) Forecasts Dramatically

Dec 03

Tread With Caution Around McPherson's Limited's (ASX:MCP) 5.0% Dividend Yield

Nov 22

Have Insiders Been Buying McPherson's Limited (ASX:MCP) Shares This Year?

Sep 10

Here's What McPherson's Limited's (ASX:MCP) Shareholder Ownership Structure Looks Like

Aug 19

McPherson's Limited (ASX:MCP) P/E Isn't Throwing Up Surprises

Jul 30

Is McPherson's Limited (ASX:MCP) Expensive For A Reason? A Look At Its Intrinsic Value

Jul 15

주주 수익률

	MCP	AU Personal Products	AU 마켓
7D	-3.7%	-9.9%	1.2%
1Y	-22.0%	53.6%	19.7%

수익률 대 산업: MCP 지난 1년 동안 53.6 %를 반환한 Australian Personal Products 업계보다 저조한 성과를 냈습니다.

수익률 대 시장: MCP 지난 1년 동안 19.7 %를 반환한 Australian 시장보다 저조한 성과를 냈습니다.

가격 변동성

Is MCP's price volatile compared to industry and market?
MCP volatility
MCP Average Weekly Movement	5.9%
Personal Products Industry Average Movement	5.7%
Market Average Movement	8.6%
10% most volatile stocks in AU Market	17.5%
10% least volatile stocks in AU Market	3.2%

안정적인 주가: MCP 는) 지난 3개월 동안 큰 가격 변동성이 없었습니다.

시간에 따른 변동성: MCP 의 주간 변동성( 6% )은 지난 1년 동안 안정적인 모습을 보였습니다.

회사 소개

설립	직원	CEO	웹사이트
1860	n/a	Brett Charlton	www.mcphersons.com.au

맥퍼슨은 호주, 뉴질랜드, 아시아 및 전 세계에 건강, 웰빙, 미용 제품을 제공하는 회사입니다. 이 회사는 미용 관리, 헤어 케어, 스킨 케어, 페이셜 티슈, 화장솜, 발 편안함 제품, 비타민 및 보충제, 향수 및 영양제를 포함한 개인 관리 품목을 제공합니다. 주로 닥터 르윈스, 에이킨, 매니케어, 레이디 제인, 스위스퍼스, 퓨전 헬스, 오리엔탈 보태니컬스, 마세르, 글램 바이 매니케어, 레비타네일, 풋케어 바이 마세르, 스트래튼 등의 브랜드로 제품을 판매하고 있습니다.

McPherson's Limited 기본 사항 요약

McPherson's 의 수익과 매출은 시가총액과 어떻게 비교하나요?
MCP 기본 통계
시가총액	AU$56.14m
수익(TTM)	-AU$11.39m
수익(TTM)	AU$144.65m

0.4x

P/S 비율

-4.9x

P/E 비율

MCP 주가가 과대평가되어 있나요?

공정 가치 및 가치 분석 보기

수익 및 수익

최신 수익 보고서의 주요 수익성 통계(TTM)
MCP 손익 계산서(TTM)
수익	AU$144.65m
수익 비용	AU$68.08m
총 이익	AU$76.58m
기타 비용	AU$87.96m
수익	-AU$11.39m

최근 보고된 수익

Jun 30, 2024

다음 수익 날짜

n/a

주당 순이익(EPS)	-0.079
총 마진	52.94%
순이익 마진	-7.87%
부채/자본 비율	11.9%

MCP 의 장기적인 성과는 어땠나요?

과거 실적 및 비교 보기

MCP 주식 개요

보상

위험 분석

McPherson's Limited 경쟁사

ASX:BWX

AU$40.0m

ASX:S66

AU$15.5m

ASX:EXL

AU$8.8m

ASX:CCO

AU$16.5m

가격 내역 및 성능

최근 뉴스 및 업데이트

McPherson's Limited, Annual General Meeting, Nov 27, 2024

New major risk - Revenue and earnings growth

Full year 2024 earnings released: AU$0.079 loss per share (vs AU$0.035 loss in FY 2023)

McPherson's Limited to Report Fiscal Year 2024 Results on Aug 29, 2024

McPherson's Limited's (ASX:MCP) Share Price Not Quite Adding Up

First half 2024 earnings released: EPS: AU$0.011 (vs AU$0.001 in 1H 2023)

Recent updates

McPherson's Limited, Annual General Meeting, Nov 27, 2024

New major risk - Revenue and earnings growth

Full year 2024 earnings released: AU$0.079 loss per share (vs AU$0.035 loss in FY 2023)

McPherson's Limited to Report Fiscal Year 2024 Results on Aug 29, 2024

McPherson's Limited's (ASX:MCP) Share Price Not Quite Adding Up

First half 2024 earnings released: EPS: AU$0.011 (vs AU$0.001 in 1H 2023)

Price target increased by 25% to AU$0.67

Upcoming dividend of AU$0.02 per share

New minor risk - Share price stability

McPherson's Limited Announces Executive Changes

McPherson's Limited's (ASX:MCP) Shares Climb 35% But Its Business Is Yet to Catch Up

Here's Why McPherson's (ASX:MCP) Can Manage Its Debt Responsibly

McPherson's Limited, Annual General Meeting, Nov 28, 2023

Price target decreased by 14% to AU$0.54

McPherson's (ASX:MCP) Will Pay A Smaller Dividend Than Last Year

Upcoming dividend of AU$0.01 per share at 4.0% yield

McPherson's Limited Announces Ordinary Fully Paid Dividend for the Six Months Ended June 30, 2023, Payable on September 22, 2023

Full year 2023 earnings: EPS and revenues miss analyst expectations

McPherson's Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

Less than half of directors are independent

A Look At The Fair Value Of McPherson's Limited (ASX:MCP)

McPherson’s Limited Appoints Brett Charlton as Chief Executive Officer, Effective 1 August 2023

Now 22% undervalued after recent price drop

Mcpherson's Limited Announces Resignation of Grant Peck as Chief Executive Officer, Effective 31 May 2023

Consensus EPS estimates fall by 29%, revenue upgraded

These 4 Measures Indicate That McPherson's (ASX:MCP) Is Using Debt Reasonably Well

Price target decreased by 7.9% to AU$0.78

Now 24% undervalued after recent price drop

First half 2023 earnings: EPS misses analyst expectations

Price target decreased by 11% to AU$0.84

Now 23% undervalued after recent price drop

McPherson's Limited Appoints Linda Gough as Company Secretary

Price target decreased to AU$0.84

McPherson's Limited to Report First Half, 2023 Results on Feb 28, 2023

Consensus forecasts updated

McPherson's Limited Announces Resignation of Geoffrey Pearce as Director, Effective November 22, 2022

McPherson's Limited, Annual General Meeting, Nov 22, 2022

Upcoming dividend of AU$0.02 per share

Full year 2022 earnings: EPS misses analyst expectations

McPherson's Limited Declares Fully Franked Final Dividend for the Year 2022, Payable on 23 September 2022

McPherson's Limited to Report Fiscal Year 2022 Results on Aug 25, 2022

First half 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Mcpherson's Limited Announces Board Changes

McPherson's Limited Announces Changes to Its Board

McPherson's Limited to Report First Half, 2022 Results on Feb 23, 2022

Price target decreased to AU$1.19

Arrotex Pharmaceuticals Pty Limited cancelled the acquisition of McPherson's Limited (ASX:MCP) from Investors Mutual Limited, Kin Group Pty Ltd, Microequities Asset Management Pty Limited, Lennox Capital Partners and others.

Price target increased to AU$1.53

Arrotex Pharmaceuticals Pty Limited made a Non-binding Indicative Offer to acquire McPherson's Limited (ASX:MCP) from Investors Mutual Limited, Kin Group Pty Ltd, Microequities Asset Management Pty Limited, Lennox Capital Partners and others for approximately AUD 210 million.

McPherson's Limited Provides Earnings Guidance for the Full Year 2021

McPherson's Limited Not Providing Earnings Guidance Due to COVID-19

McPherson's Limited Appoints Ari Mervis as Independent, Non-Executive Director to the Board

Did You Participate In Any Of McPherson's' (ASX:MCP) Fantastic 149% Return ?

McPherson's Limited to Report First Half, 2021 Results on Feb 17, 2021

Are McPherson's's (ASX:MCP) Statutory Earnings A Good Guide To Its Underlying Profitability?

Declining Stock and Decent Financials: Is The Market Wrong About McPherson's Limited (ASX:MCP)?

A Look At The Intrinsic Value Of McPherson's Limited (ASX:MCP)

Investor sentiment improved over the past week

McPherson's CEO Change